Tags » Device

Delcath's European Key Opinion Leader Forum On CHEMOSAT Therapy Affirms Benefits To Liver Cancer Patients

NEW YORK, May 27, 2015 /PRNewswire/ — Delcath Systems, Inc. (NASDAQ: DCTH), a specialty pharmaceutical and medical device company focused on oncology with an emphasis on the treatment of primary and metastatic liver cancers, announces findings from its recent three-day Key Opinion Leader Forum that focused on CHEMOSAT®, the Company’s percutaneous hepatic perfusion (PHP) therapy for the treatment of liver cancers.  667 more words

Preclinical & Clinical

Moovs arrive

Two Moovs arrived today – I will be evaluating them and contacting them for access to their developer programme.


Klipp Concept Camera

Rate This Concept Now!

Overview: The Funamizu is back with another concept. Inspired by the WVIL concept camera shown at this year’s CES, Mac Funamizu envisaged a similar device in a slimmer package. 38 more words

Product Design

SciBase Receives US Patent Approval for Its Electrodes with Micro-Needles

STOCKHOLM–(BUSINESS WIRE)–SciBase, a Swedish medtech company that develops and markets a new method for early detection of malignant melanoma, has received approval from the United States Patent and Trademark Office (USPTO) regarding its patent application for its electrodes with micro-needles. 403 more words

Advanced Melanoma

視線追跡機能付きVRのFOVEがKickstarterキャンペーンを開始 [ #cbajp ]

FOVE」(フォーブ)はOculus VRのようなヘッドマウントディスプレイ(HMD)に視線追跡機能を付加したものを開発している日本発のスタートアップだ。今回のKickstarterキャンペーンに伴い FOVEについてアップデートしておこう。



人間の目の動きでコントロールするVRヘッドセットFOVEがKickstarterで予約販売を開始 [ #cbajp ]

目の動きでコントロールできる仮想現実(virtual reality, VR)ヘッドセットFOVEが、Kickstarterで予約販売を開始した。この東京のスタートアップは、昨年のTechCrunch Disrupt San Franciscoでファイナリストになり、今回Kickstarter上では締め切りまで44日を残す今日(米国時間5/20)、目標額25万ドルの2/3以上を達成している*。〔*: 日本時間5/21 12:00では21万ドルを突破。〕



Try Eventbase to create an app for your event.

Try Eventbase to create an app for your event.

Create your event app at http://eventbase.com/ The Eventbase app is available from the iOS and Google app stores. 61 more words